Greater Cannabis Company (GCAN) Depreciation & Amortization (CF) (2020 - 2023)
Greater Cannabis Company (GCAN) recorded quarterly Depreciation & Amortization (CF) of $1250.0 in Q4 2023, little changed quarter-over-quarter from $1250.0 in Q3 2023, and little changed on a YoY basis from $1250.0 in Q4 2022.
Greater Cannabis Company (GCAN) Depreciation & Amortization (CF) (2020 - 2023) Analysis & Trends
Greater Cannabis Company's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $1250.0 for Q4 2023.
- In Q4 2023, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1250.0; the TTM figure through Sep 2024 stood at $1250.0 (down 75.0% YoY), while the FY2023 annual figure was $5000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) was $1250.0 for Q4 2023 at Greater Cannabis Company, roughly flat from $1250.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $1250.0 in Q2 2020 to a low of $833.0 in Q1 2020.
- Historically, Depreciation & Amortization (CF) has averaged $1223.9 across 4 years, with a median of $1250.0 in 2020.
- Biggest YoY gain for Depreciation & Amortization (CF) was 50.06% in 2021; the steepest drop was 0.0% in 2021.
- A 4-year view of Depreciation & Amortization (CF) shows it stood at $1250.0 in 2020, then changed by 0.0% to $1250.0 in 2021, then changed by 0.0% to $1250.0 in 2022, then changed by 0.0% to $1250.0 in 2023.
- The last three Depreciation & Amortization (CF) figures came in at $1250.0 (Q4 2023), $1250.0 (Q3 2023), and $1250.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 21.95 Mn |
| 10 | Greater Cannabis Company | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,250.00 |
| Dec 31, 2023 | 1,250.00 |
| Sep 30, 2023 | 1,250.00 |
| Sep 30, 2023 | 1,250.00 |
| Jun 30, 2023 | 1,250.00 |
| Jun 30, 2023 | 1,250.00 |
| Mar 31, 2023 | 1,250.00 |
| Mar 31, 2023 | 1,250.00 |
| Dec 31, 2022 | 1,250.00 |
| Dec 31, 2022 | 1,250.00 |
| Sep 30, 2022 | 1,250.00 |
| Sep 30, 2022 | 1,250.00 |
| Jun 30, 2022 | 1,250.00 |
| Jun 30, 2022 | 1,250.00 |
| Mar 31, 2022 | 1,250.00 |
| Mar 31, 2022 | 1,250.00 |
| Dec 31, 2021 | 1,250.00 |
| Dec 31, 2021 | 1,250.00 |
| Sep 30, 2021 | 1,250.00 |
| Sep 30, 2021 | 1,250.00 |